Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Brachytherapy × Clear all

Status

Terminated 4 Completed 4 Unknown 2 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 7 Uterine Cervical Neoplasms 6 Endometrial Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Locally Advanced Cervical Adenocarcinoma 1 Hyperthermia 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Clear Cell Adenocarcinoma 1 Directly Observed Therapy 1 Carcinoma, Renal Cell 1 Adenocarcinoma 1

Interventions

pembrolizumab 31 Blood Specimen Collection 29 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 14 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Cisplatin 11 atezolizumab 10 Drug Therapy 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 9 Pemetrexed 8 Fluorouracil 8 olaparib 7 Trastuzumab 7 Temozolomide 7 Leucovorin 7 Irinotecan 7 Interviews as Topic 7 Cetuximab 7 pertuzumab 6 Radiosurgery 6 Panitumumab 6 Oxaliplatin 6 Observation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01255748 2025-09-09

Registry Study for Radiation Therapy Outcomes

Proton Collaborative Group

40,000 enrolled

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡